124 related articles for article (PubMed ID: 1615971)
1. Deoxyribonucleic acid analysis by flow cytometry of uterine leiomyosarcomas and smooth muscle tumors of uncertain malignant potential.
Peters WA; Howard DR; Andersen WA; Figge DC
Am J Obstet Gynecol; 1992 Jun; 166(6 Pt 1):1646-53; discussion 1653-4. PubMed ID: 1615971
[TBL] [Abstract][Full Text] [Related]
2. Uterine leiomyosarcomas and benign smooth muscle tumors: usefulness of nuclear DNA patterns studied by flow cytometry.
Tsushima K; Stanhope CR; Gaffey TA; Lieber MM
Mayo Clin Proc; 1988 Mar; 63(3):248-55. PubMed ID: 3343869
[TBL] [Abstract][Full Text] [Related]
3. Uterine smooth-muscle tumors of uncertain malignant potential.
Peters WA; Howard DR; Andersen WA; Figge DC
Obstet Gynecol; 1994 Jun; 83(6):1015-20. PubMed ID: 8190416
[TBL] [Abstract][Full Text] [Related]
4. The prognostic significance of stage, tumor size, cellular atypia and DNA ploidy in uterine leiomyosarcoma.
Nordal RR; Kristensen GB; Kaern J; Stenwig AE; Pettersen EO; Tropé CG
Acta Oncol; 1995; 34(6):797-802. PubMed ID: 7576748
[TBL] [Abstract][Full Text] [Related]
5. Leiomyosarcoma of the uterus: A clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 49 cases.
Blom R; Guerrieri C; Stâl O; Malmström H; Simonsen E
Gynecol Oncol; 1998 Jan; 68(1):54-61. PubMed ID: 9454661
[TBL] [Abstract][Full Text] [Related]
6. Proliferation, ploidy and prognosis in uterine smooth muscle tumours.
Jeffers MD; Oakes SJ; Richmond JA; Macaulay EM
Histopathology; 1996 Sep; 29(3):217-23. PubMed ID: 8884349
[TBL] [Abstract][Full Text] [Related]
7. Prognostic parameters for survival of patients with malignant mesenchymal tumors of the uterus.
Nola M; Babić D; Ilić J; Marusić M; Uzarević B; Petrovecki M; Sabioncello A; Kovac D; Jukić S
Cancer; 1996 Dec; 78(12):2543-50. PubMed ID: 8952563
[TBL] [Abstract][Full Text] [Related]
8. Leiomyosarcomas and benign smooth muscle tumors of the stomach: nuclear DNA patterns studied by flow cytometry.
Tsushima K; Rainwater LM; Goellner JR; van Heerden JA; Lieber MM
Mayo Clin Proc; 1987 Apr; 62(4):275-80. PubMed ID: 3561042
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric analysis of uterine sarcoma: ploidy and S-phase rate as prognostic indicators.
Malmström H; Schmidt H; Persson PG; Carstensen J; Nordenskjöld B; Simonsen E
Gynecol Oncol; 1992 Feb; 44(2):172-7. PubMed ID: 1544595
[TBL] [Abstract][Full Text] [Related]
10. Correlation between DNA ploidy and clinical features in smooth muscle tumors of the gastrointestinal tract.
Kimura H; Yonemura Y; Kadoya N; Kosaka T; Miwa K; Miyazaki I; Sawa T; Yoshimitsu S; Nishida Y; Kamata T
Anal Cell Pathol; 1993 Nov; 5(6):331-8. PubMed ID: 8305329
[TBL] [Abstract][Full Text] [Related]
11. Smooth muscle tumors of the gastrointestinal tract: analysis of prognostic factors.
Chou FF; Eng HL; Sheen-Chen SM
Surgery; 1996 Feb; 119(2):171-7. PubMed ID: 8571202
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometric DNA analysis of gastric smooth muscle tumors.
Shimamoto T; Haruma K; Sumii K; Kajiyama G; Tahara E
Cancer; 1992 Oct; 70(8):2031-4. PubMed ID: 1394032
[TBL] [Abstract][Full Text] [Related]
13. Uterine smooth muscle tumors: utility of classification by proliferation, ploidy, and prognostic markers versus traditional histopathology.
Layfield LJ; Liu K; Dodge R; Barsky SH
Arch Pathol Lab Med; 2000 Feb; 124(2):221-7. PubMed ID: 10656730
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric analysis of DNA ploidy, percent S-phase fraction, and total proliferative fraction as prognostic indicators of local control and survival following radiation therapy for prostate carcinoma.
Centeno BA; Zietman AL; Shipley WU; Sobczak ML; Shipley JW; Preffer FI; Boyle BJ; Colvin RB
Int J Radiat Oncol Biol Phys; 1994 Sep; 30(2):309-15. PubMed ID: 7928459
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometric deoxyribonucleic acid index: a prognostic factor in endometrial carcinoma.
Iversen OE
Am J Obstet Gynecol; 1986 Oct; 155(4):770-6. PubMed ID: 3766632
[TBL] [Abstract][Full Text] [Related]
16. Deoxyribonucleic acid analysis facilitates the pretreatment identification of high-risk endometrial cancer patients.
Podratz KC; Wilson TO; Gaffey TA; Cha SS; Katzmann JA
Am J Obstet Gynecol; 1993 Apr; 168(4):1206-13; discussion 1213-5. PubMed ID: 8475967
[TBL] [Abstract][Full Text] [Related]
17. [DNA flow cytometry in smooth muscle tumors of the gastrointestinal tract].
Sugihira N; Matsumoto K; Tada T; Fujino I; Urata H; Yamamoto T; Suzuki H
Gan To Kagaku Ryoho; 1993 Apr; 20(6):713-6. PubMed ID: 8489272
[TBL] [Abstract][Full Text] [Related]
18. DNA ploidy in endometrial carcinoma: major objective prognostic factor.
Britton LC; Wilson TO; Gaffey TA; Cha SS; Wieand HS; Podratz KC
Mayo Clin Proc; 1990 May; 65(5):643-50. PubMed ID: 2348728
[TBL] [Abstract][Full Text] [Related]
19. DNA ploidy, proliferation index, grade, and stage as prognostic factors for vulvar squamous cell carcinomas.
Dolan JR; McCall AR; Gooneratne S; Walter S; Lansky DM
Gynecol Oncol; 1993 Feb; 48(2):232-5. PubMed ID: 8428696
[TBL] [Abstract][Full Text] [Related]
20. [Gastrointestinal smooth muscle tumors: a study of DNA content and the association with clinicopathology].
Cai J; Jiang Y; Zhang Y
Zhonghua Bing Li Xue Za Zhi; 1995 Dec; 24(6):378-80. PubMed ID: 8732098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
